Overview of N11005 Prandial Oral Insulin
Current oral insulin developments are focused on basal insulin, N11005 has the potential to be the first prandial oral insulin, it offers several advantages for overall glycemic control.
N11005 Mimics Natural Insulin Action Profile
Natural Insulin Secretion Pathway
Injected Insulin Pathway in Diabetic Patients
N11005 Mimics Natural Insulin Secretion Pathway
